Loading
 Mr. Michael

Mr. Michael

กลุ่มวิชามนุษยศาสตร์,
Faculty of Humanities and Social Sciences,
Khon Kaen University

Documents

TCI อ้างอิงจาก http://www.tci-thaijo.org/

0

SCOPUS

0

PUBMED

0

ISI

0

TCI

Title Author Year SCOPUS PUBMED ISI TCI
1. Nitrogen loss from Titan VI Shematovich
RE Johnson
M Michael
JG Luhmann
2003
2. Ejection of nitrogen from Titan's atmosphere by magnetospheric ions and pick-up ions M Michael
RE Johnson
F Leblanc
M Liu
JG Luhmann
VI Shematovich
2005
3. Energy deposition of pickup ions and heating of Titan's atmosphere M Michael
RE Johnson
2005
4. A phase I/II trial of celecoxib with chemotherapy and radiotherapy in the treatment of patients with locally advanced oesophageal cancer S. J. Dawson
M. Michael
J. Biagi
K. F. Foo
M. Jefford
S. Y. Ngan
T. Leong
A. Hui
A. D. Milner
R. J. S. Thomas
J. R. Zalcberg
2007
5. Cassini Ion and Neutral Mass Spectrometer data in Titan's upper atmosphere and exosphere: Observation of a suprathermal corona V. De la Haye
J. H. Waite
R. E. Johnson
R. V. Yelle
T. E. Cravens
J. G. Luhmann
W. T. Kasprzak
D. A. Gell
B. Magee
F. Leblanc
M. Michael
S. Jurac
I. P. Robertson
2007
6. Gemcitabine with a specific conformal 3D 5FU radiochemotherapy technique is safe and effective in the definitive management of locally eadvanced pancreatic cancer D. Goldstein
G. Van Hazel
E. Walpole
C. Underhill
D. Kotasek
M. Michael
J. Shapiro
T. Davies
W. Reece
J. Harvey
N. Spry
2007
7. A phase II trial of lomeguatrib and temozolomide in metastatic colorectal cancer O. A. Khan
M. Ranson
M. Michael
I. Olver
N. C. Levitt
P. Mortimer
A. J. Watson
G. P. Margison
R. Midgley
M. R. Middleton
2008
8. Dust charging and electrical conductivity in the day and nighttime atmosphere of Mars M. Michael
S. N. Tripathi
S. K. Mishra
2008
9. Cetuximab plus chemotherapy in patients with advanced non-small-cell lung cancer (FLEX): an open-label randomised phase III trial Robert Pirker
Jose R. Pereira
Aleksandra Szczesna
Joachim von Pawel
Maciej Krzakowski
Rodryg Ramlau
Ihor Vynnychenko
Keunchil Park
Chih-Teng Yu
Valentyn Ganul
Jae-Kyung Roh
Emilio Bajetta
Kenneth O'Byrne
Filippo de Marinis
Wilfried Eberhardt
Thomas Goddemeier
Michael Emig
Ulrich Gatzemeier
N. Thatcher
J. P. Armand
P. Camus
N. Victor
M. Emig
M. Mueser
K. Pilz
T. Goddemeier
I. Montaner
Martin Lachs
Loan Hoang-Sayag
A. Alvarez
F. Coppola
G. Recondo
E. Richardet
F. Kirsten
C. Karapetis
P. Parente
M. Michael
S. White
A. Boyce
C. Lewis
M. Slancar
N. Pavlakis
E. Abdi
C. Underhill
K. Pittman
O. Burghuber
R. Pirker
R. Ruckser
E. Ulsperger
R. Kolb
Y. Humblet
J-L. Canon
F. Bustin
C. Barrios
C. Gorini
C. Moreira Ferreira
J. Pereira
N. Ivanova
A. Tomova
V. Tzekova
P. Chilingirov
M. Racheva
M. Gill
F. Javier Orlandi
J. Reyes
P. Salman
M. Tomiskova
J. Roubec
M. Pesek
J. Musil
P. Zatloukal
G. Robinet
A. Riviere
D. Moro-Sibilot
F. Barlesi
C. Chouaid
J-M. Tourani
H. Lena
L. Thiberville
E. Quoix
R. Schott
E. Lemarie
G. Schlimok
R. Loddenkemper
W. Eberhardt
H. Wilke
U. Martens
C. Waller
J. von Pawel
F. Griesinger
U. Gatzemeier
W. Schuette
C. Eschbach
H. Bischoff
A. Chemaissani
J. Wolf
J. Fischer
S. Bohnet
H. Klein
C. Kortsik
C. Peschel
T. H. Ittel
W. Fett
D. Chua
P. Magyar
G. Ostoros
A. Somfay
I. Vinkler
Z. Papai
B. Szima
Z. Mark
S. Tehenes
K. O'Byrne
A. Brandes
A. Martoni
G. Marini
F. Artioli
E. Bajetta
S. Siena
F. de Marinis
A. Santoro
S. Barni
G. Berchem
O. Arrieta
J. Figueroa
L. Martinez
E. Llerena
J. A. Burgers
G. Giaccone
F. M. N. H. Schramel
S. H. Goey
J. A. Stigt
G. Jagiello
A. Jagiello-Gruszfeld
A. Szczesna
R. Ramlau
M. Krzakowski
J. Tomeczko
E. Teixeira
B. Parente
G. Kononova
M. Biakhov
V. Borisov
V. Gorbunova
A. Konev
L. Manzuk
Y. Lukyanov
G. Manikhas
S. Orlov
D-S. Heo
S-W. Kim
K. Park
J-K. Roh
J-H. Choi
R. Soo
J. Mazal
P. Kasan
P. Berzinec
M. Prochazka
A. Carrato
R. Bastus Pivlots
P. Lianes
J. Villar
L. Paz-Ares
M. Cobo
J. M. Trigo
A. Gurpide Ayarra
M. Constenla
A. Paredes Lario
M. Lopez Brea
A. Insa
G. Lopez Vivanco
O. Brodin
G. Wagenius
A. Ochsenbein
D. Rauch
A. Knuth
G-C. Chang
R. P. Perng
C-H. Yang
C-T. Yu
A. Demirkazik
F. Demirelli
M. Nicolson
S. Falk
A. Price
C. Mulatero
S. M. Lee
M. O'Brien
J. Gardiner
V. Laurence
D. Ferry
V. Paramonov
I. Bondarenko
M. Pylypenko
V. Ganul
P. Oliynichenko
S. Simonov
Y. Shparyk
V. Bashtan
I. Vynnychenko
I. Galaychuk
Y. Hotko
2009
10. Molecular markers of response and toxicity to FOLFOX chemotherapy in metastatic colorectal cancer W. Chua
D. Goldstein
C. K. Lee
H. Dhillon
M. Michael
P. Mitchell
S. J. Clarke
B. Iacopetta
2009
11. Safety and efficacy of first-line bevacizumab with FOLFOX, XELOX, FOLFIRI and fluoropyrimidines in metastatic colorectal cancer: the BEAT study E. Van Cutsem
F. Rivera
S. Berry
A. Kretzschmar
M. Michael
M. DiBartolomeo
M. -A. Mazier
J. -L. Canon
V. Georgoulias
M. Peeters
J. Bridgewater
D. Cunningham
2009
12. BENDAMUSTINE IN PATIENTS WITH RELAPSED OR REFRACTORY MULTIPLE MYELOMA M. Michael
I. Bruns
E. Boelke
F. Zohren
A. Czibere
N. N. Safaian
F. Ncumann
R. Haas
G. Kobbe
R. Fenk
2010
13. Open-label, phase I dose-escalation study of sodium selenate, a novel activator of PP2A, in patients with castration-resistant prostate cancer N. M. Corcoran
C. M. Hovens
M. Michael
M. A. Rosenthal
A. J. Costello
2010
14. Plant breeding and climate changes S. Ceccarelli
S. Grando
M. Maatougui
M. Michael
M. Slash
R. Haghparast
M. Rahmanian
A. Taheri
A. Al-Yassin
A. Benbelkacem
M. Labdi
H. Mimoun
M. Nachit
2010
15. FDG-PET metabolic response predicts outcomes in anal cancer managed with chemoradiotherapy F. L. Day
E. Link
S. Ngan
T. Leong
K. Moodie
C. Lynch
M. Michael
E. de Winton
A. Hogg
R. J. Hicks
A. Heriot
2011
16. Metabolic Response of Rectal Cancer Assessed by 18-FDG PET Following Chemoradiotherapy is Prognostic for Patient Outcome J. M. C. Yeung
V. Kalff
R. J. Hicks
E. Drummond
E. Link
Y. Taouk
M. Michael
S. Ngan
A. C. Lynch
A. G. Heriot
2011
17. ACTING PSYCHIATRY C. Hickie
M. Michael
2014
18. Additive glycaemic control of the combination of a single dose of empagliflozin with injectable antidiabetes drugs in ZDF rats E. K. Naderali
L. Thomas
R. Grempler
M. Michael
E. Mayoux
A. Tahbaz
2014
19. A Phase II Trial of Integrated Preoperative Radiotherapy and Chemotherapy with Oxaliplatin 5-Fluorouracil and Folinic Acid in Patients with Locally Advanced Rectal Cancer: Trans-Tasman Radiation Oncology Group TROG 09.01 S. Ngan
M. Bressel
B. McClure
S. Chander
J. McKendrick
M. Steel
J. Mackay
P. Cooray
M. Kumar
A. Strickland
A. Heriot
T. Leong
M. Michael
2014
20. Assessment of predictors of response and long-term survival of patients with neuroendocrine tumour treated with peptide receptor chemoradionuclide therapy (PRCRT) G. Kong
M. Thompson
M. Collins
A. Herschtal
M. S. Hofman
V. Johnston
P. Eu
M. Michael
Rodney J. Hicks
2014
21. AUDIT OF UPPER GI UNIT REFERRALS TO THE FAMILIAL CANCER CENTRE T. Schenberg
M. Michael
2014
22. CREATIVE PRACTITIONERS S. Kumar
C. Hickie
L. McLean
M. Michael
A. Pal
N. Phillips
2014
23. Disruption of cortical tension patterning drives the outgrowth of oncogenic cells S. Wu
G. A. Gomez
M. Michael
S. Verma
H. Cox
J. G. Lefevre
R. G. Parton
N. A. Hamilton
A. S. Yap
2014
24. Phase II trial evaluating the feasibility of interdigitating folfox with chemoradiotherapy in locally advanced and metastatic rectal cancer M. Michael
S. Chander
J. McKendrick
J. R. MacKay
M. Steel
R. Hicks
A. Heriot
T. Leong
P. Cooray
M. Jefford
J. Zalcberg
M. Bressel
B. McClure
S. Y. Ngan
2014
25. Practicing Excellence in Transfusion: The Results of a Performance Improvement Project to Reduce Red Blood Cell Utilization at Virginia Commonwealth University, Richmond, Virginia M. Michael
B. Dahman
S. Roseff
M. Ailes
N. Benoit
2014
26. Preserved levels of uninvolved immunoglobulins are independently associated with favorable outcome in patients with symptomatic multiple myeloma E. Kastritis
F. Zagouri
A. Symeonidis
M. Roussou
A. Sioni
A. Pouli
S. Delimpasi
E. Katodritou
E. Michalis
M. Michael
E. Hatzimichael
A. Vassou
P. Repousis
A. Christophoridou
Z. Kartasis
E. Stefanoudaki
C. Megalakaki
S. Giannouli
M-C Kyrtsonis
K. Konstantopoulos
M. Spyroupoulou-Vlachou
E. Terpos
M. A. Dimopoulos
2014
27. Prison health as public health in Afghanistan? A policy analysis of the on-going reform process M. Michael 2014
28. Significant improvement in the survival of patients with multiple myeloma presenting with severe renal impairment after the introduction of novel agents M. A. Dimopoulos
S. Delimpasi
E. Katodritou
A. Vassou
M. C. Kyrtsonis
P. Repousis
Z. Kartasis
A. Parcharidou
M. Michael
E. Michalis
D. Gika
A. Symeonidis
A. Pouli
K. Konstantopoulos
E. Terpos
E. Kastritis
2014
29. Single dose of empagliflozin in combination with other oral antidiabetes drugs further improves glucose tolerance in ZDF rats A. Tahbaz
G. Luippold
L. Thomas
M. Michael
E. Mayoux
E. K. Naderali
2014
30. SOCIAL CONSTRAINT AMONGST PEOPLE WITH ADVANCED CANCER: A CORRELATE WITH STIGMATISATION AND ANXIETY Nicole Hennessy Anderson
P. Schofield
S. Aranda
S. Chambers
M. Krishnasamy
D. Ball
M. Michael
P. Kenny
R. Lipson-Smith
I. Stubbins
A. Ugalde
2014
31. The effects of empagliflozin, a novel sodium glucose cotransporter-2 inhibitor, on glucose homeostasis and pancreatic beta cell mass in db/db mice E. Mayoux
T. Klein
R. Grempler
M. Michael
A. Tahbaz
E. K. Naderali
2014
32. The novel SGLT-2 inhibitor, empagliflozin, prevents pioglitazone-induced weight gain and further improves glycaemic control in dietary-induced obese rats E. K. Naderali
R. Grempler
L. Thomas
A. Sauer
M. Michael
P. Eickelmann
T. Klein
E. Mayoux
A. Tahbaz
2014
33. The Safety and Tolerability of Veliparib (V) plus Capecitabine (C) and Radiation (RT) in Subjects with Locally Advanced Rectal Cancer (LARC): Results of a Phase 1b Study B. Czito
M. Mulcahy
W. Schelman
H. Vaghefi
J. Gayle
A. Deluca
H. Xiong
W. Munasinghe
D. Matthew
K. Holen
M. Michael
2014
34. Validation of radio-frequency dielectric heating system for destruction of Cronobacter sakazakii and Salmonella species in nonfat dry milk M. Michael
R. K. Phebus
H. Thippareddi
J. Subbiah
S. L. Birla
K. A. Schmidt
2014
35. Safety and Tolerability of Veliparib Combined With Capecitabine Plus Radiation Therapy in Patients With Locally Advanced Rectal Cancer: Final Results of a Phase 1b Study B. Czito
M. Mulcahy
D. Deming
H. Vaghefi
G. Jameson
A. DeLuca
H. Xiong
W. Munasinghe
M. Dudley
P. Komarnitsky
K. Holen
M. Michael
2015
36. The Clinical Oncology Society of Australia (COSA) SIGNETURe Neuroendocrine Tumor (NET) Registry of Australia: First Report of Patient Characteristics and Patterns of Care T. Price
N. Pavlakis
C. Karapetis
M. Michael
N. Singhal
D. Goldstein
G. Van Hazel
J. Zalcberg
R. Hicks
S. Yeend
Y. J. Chua
2015
37. A 12-week regimen with interdigitating FOLFOX/bevacizumab and pelvic chemoradiation for synchronous primary and metastatic rectal cancer. The CHROME B trial S. Ngan
M. Bressel
J. Chu
J. McKendrick
S. Chander
P. Cooray
M. Jefford
R. Wong
M. Steel
T. Leong
A. Heriot
M. Michael
2016
38. A photochemicalmodel of the dust-loaded ionosphere of Mars S. Cardnell
O. Witasse
G. J. Molina-Cuberos
M. Michael
S. N. Tripathi
G. Deprez
F. Montmessin
K. O'Brien
2016
39. Favourable responses in Patients with Bulky Neuroendocrine Tumours (NET) A Personalised Approach Using 90Y-DOTA-Octreotate Sequenced with 177Lu-DOTA-Octreotate Induction Peptide Receptor Chemoradionuclide Therapy (PRCRT) G. Kong
J. Callahan
M. Hofman
D. Pattison
T. Akhurst
M. Michael
P. Eu
R. Hicks
2016
40. Genomic Variants in the SLCO1B3 Gene May Serve as Pharmacogenomic Biomarkers upon Cancer Drug Administration A. Stratopoulos
M. Michael
C. -V. Zafeiri
E. Daki
T. Katsila
G. P. Patrinos
2016
41. HIGH EFFICACY FROM A PERSONALISED APPROACH USING Y-90-DOTA-OCTREOTATE SEQUENCED WITH (LU)-L-177-DOTA-OCTREOTATE INDUCTION PEPTIDE RECEPTOR CHEMORADIONUCLIDE THERAPY (PRCRT) FOR BULKY NEUROENDOCRINE TUMOURS G. Kong
J. Callahan
M. Hofman
D. Pattison
T. Akhurst
M. Michael
P. Eu
R. Hicks
2016
42. Ledipasvir/Sofosbuvir (LDV/SOF) for 12 or 24 Weeks Is Safe and Effective in Kidney Transplant Recipients with Chronic Genotype 1 or 4 HCV Infection S. Pol
A. Aghemo
L. Lin
R. Hyland
C. Yun
J. Spellman
M. Natha
D. Brainard
J. McHutchison
M. Bourliere
M. Peck-Radosavljevic
M. Michael
M. Colombo
2016
43. PRELIMINARY RESULTS OF (68)GA EXENDIN-4 PET/CT IMAGING OF NEUROENDOCRINE TUMOURS (NETS) D. Pattison
G. Kong
B. Messazos
P. Hamblin
S. Fourlanos
M. Lee
M. Michael
E. Hong
P. Eu
R. Hicks
2016
44. THE ENDOTHELIAL PHD2/HIF-2 AXIS REGULATES PULMONARY ARTERY PRESSURE IN MICE P. P. Kapitsinou
G. Rajendran
L. Astleford
M. P. Schonfeld
M. Michael
S. Shay
J. L. French
J. West
V. H. Haase
T. Fields
2016
45. UNIVERSITY OF SOUTH FLORIDA, TAMPA FAMILY HEALTH CENTER, AND SENIOR CONNECTION PARTNERSHIP R. DAoust
K. Hyer
L. Guerra
A. Badana
F. Syed
C. McHenry
M. Michael
C. Wilson
2016
46. Application of Curriculum Mapping Concepts to Integrate Multidisciplinary Competencies in the Care of Older Adults in Graduate Nurse Practitioner Curricula C. Burkey-Wilson
M. Michael
2017
47. A REVISED STAGING SYSTEM FOR WALDENSTROM'S MACROGLOBULINEMIA E. Kastritis
M. Gavriatopoulou
M. C. Kyrtsonis
E. Hatjiharissi
E. Katodritou
P. Repousis
A. Symeonidis
M. Michael
A. Pouli
N. Giannakoulas
D. Christoulas
A. Megalakaki
P. Tsirigotis
S. Giannouli
P. Panagiotidis
E. Vervessou
E. Spanoudakis
E. Terpos
M. A. Dimopoulos
2017
48. FOLFOX and intensified split-course chemoradiation as initial treatment for rectal cancer with synchronous metastases Bird, T
Michael, M
Bressel, M
Chu, J
Chander, S
Cooray, P
McKendrick, J
Jefford, M
Heriot, A
Steel, M
Leong, T
Ngan, S
2017
49. Midpole Ureterocalycostomy for Renal Transplant Salvage: A Pediatric Case Report. Imani, PD
White, JT
Michael, M
Puttmann, KT
O'Mahony, CA
Koh, CJ
2018
50. Prognostic value of tumour regression grade in locally advanced rectal cancer: a systematic review and meta-analysis. Kong, JC
Guerra, GR
Warrier, SK
Lynch, AC
Michael, M
Ngan, SY
Phillips, W
Ramsay, G
Heriot, AG
2018
51. [Systematic analysis of airway registries in emergency medicine]. Girrbach, FF
Hilbig, F
Michael, M
Bernhard, M
2018
52. [36-years-old male following motorcycle accident with high velocity trauma : Preparation for the medical specialist examination: part 34]. Michael, M
Picker, O
Bernhard, M
2019
53. [Resuscitation room management for trauma patients]. Thelen, S
Michael, M
Ashmawy, H
Knoefel, WT
Picker, O
Windolf, J
Bernhard, M
2019
54. Prognostic factors influencing survival in patients undergoing cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for isolated colorectal peritoneal metastases: a systematic review and meta-analysis. Narasimhan, V
Tan, S
Kong, J
Pham, T
Michael, M
Ramsay, R
Warrier, S
Heriot, A
2020
55. An Experimental Study on the Rheological Behavior of Carbon Black-Boron Nitride Hybrid Nanofluids and Development of a New Correlation. Michael, M
Zagabathuni, A
Kumar Pabi, S
Ghosh, S
2021
56. Association between imaging response and survival following neoadjuvant chemotherapy in patients with resectable colorectal liver metastases: A cohort study. Behrenbruch, C
Prabhakaran, S
Udayasiri D, D
Michael, M
Hollande, F
Hayes, I
Heriot, AG
Knowles, B
Thomson, BN
2021
57. Complete pathological response in rectal cancer utilising novel treatment strategies for neo-adjuvant therapy: A systematic review. Wilson, K
Flood, M
Narasimhan, V
Pham, T
Warrier, S
Ramsay, R
Michael, M
Heriot, A
2021
58. Dural Venous Sinus Stenosis: Why Distinguishing Intrinsic-versus-Extrinsic Stenosis Matters. Sundararajan, SH
Ramos, AD
Kishore, V
Michael, M
Doustaly, R
DeRusso, F
Patsalides, A
2021
59. Immune Checkpoint Blockade in Lower Gastrointestinal Cancers: A Systematic Review. Wilson, KC
Flood, MP
Oh, D
Calvin, N
Michael, M
Ramsay, RG
Heriot, AG
2021
60. Impact of gas micro-nano-bubbles on the efficacy of commonly used antimicrobials in the food industry. Singh, A
Sekhon, AS
Unger, P
Babb, M
Yang, Y
Michael, M
2021
61. [Nontraumatic resuscitation room management of critically ill patients]. Michael, M
Kumle, B
Pin, M
Kümpers, P
Gröning, I
Bernhard, M
2021
62. [Optimization of microbial diagnostics by introduction of a blood culture standard operating procedure in the emergency department]. Orth, HM
Al Agha, S
Kempe, M
Mackenzie, C
Michael, M
Bernhard, M
Jensen, B-O
2021
63. TEMPORARY REMOVAL: OC-15: Targeted thromboprophylaxis in ambulatory patients receiving anticancer therapies for lung or gastrointestinal cancers (TARGET-TP); a randomized trial. Alexander, M
Harris, SJ
Underhill, C
Torres, J
Sharma, S
Lee, N
Wong, H
Eek, R
Michael, M
Tie, J
Rogers, J
Heriot, A
Ball, D
MacManus, M
Wolfe, R
Solomon, B
Burbury, K
2022
64. TEMPORARY REMOVAL: PO-44: Risk assessment model potency to detect patients most likely to benefit from thromboprophylaxis: an application of the TARGET- TP score. Alexander, M
Harris, SJ
Underhill, C
Torres, J
Sharma, S
Lee, N
Wong, H
Eek, R
Michael, M
Tie, J
Rogers, J
Heriot, A
Ball, D
MacManus, M
Wolfe, R
Solomon, B
Burbury, K
2022
Count 0 17 48 0

Title Authors Year Publication name Cited count
< 2017 2018 2019 2020 2021 2022 Total

Title Authors Year Journal title
1. FOLFOX and intensified split-course chemoradiation as initial treatment for rectal cancer with synchronous metastases. Bird, T
Michael, M
Bressel, M
Chu, J
Chander, S
Cooray, P
McKendrick, J
Jefford, M
Heriot, A
Steel, M
Leong, T
Ngan, S
2017 Acta oncologica (Stockholm, Sweden)
(), pp. 1-7
2. [Systematic analysis of airway registries in emergency medicine]. Girrbach, FF
Hilbig, F
Michael, M
Bernhard, M
2018 Der Anaesthesist
9 (67), pp. 664-673
3. Prognostic value of tumour regression grade in locally advanced rectal cancer: a systematic review and meta-analysis. Kong, JC
Guerra, GR
Warrier, SK
Lynch, AC
Michael, M
Ngan, SY
Phillips, W
Ramsay, G
Heriot, AG
2018 Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland
7 (20), pp. 574-585
4. Midpole Ureterocalycostomy for Renal Transplant Salvage: A Pediatric Case Report. Imani, PD
White, JT
Michael, M
Puttmann, KT
O'Mahony, CA
Koh, CJ
2018 Transplantation proceedings
3 (50), pp. 887-890
5. [36-years-old male following motorcycle accident with high velocity trauma : Preparation for the medical specialist examination: part 34]. Michael, M
Picker, O
Bernhard, M
2019 Der Anaesthesist
0 (68), pp. 239-242
6. [Resuscitation room management for trauma patients]. Thelen, S
Michael, M
Ashmawy, H
Knoefel, WT
Picker, O
Windolf, J
Bernhard, M
2019 Der Anaesthesist
1 (68), pp. 49-66
7. Prognostic factors influencing survival in patients undergoing cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for isolated colorectal peritoneal metastases: a systematic review and meta-analysis. Narasimhan, V
Tan, S
Kong, J
Pham, T
Michael, M
Ramsay, R
Warrier, S
Heriot, A
2020 Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland
11 (22), pp. 1482-1495
8. Immune Checkpoint Blockade in Lower Gastrointestinal Cancers: A Systematic Review. Wilson, KC
Flood, MP
Oh, D
Calvin, N
Michael, M
Ramsay, RG
Heriot, AG
2021 Annals of surgical oncology
12 (28), pp. 7463-7473
9. [Optimization of microbial diagnostics by introduction of a blood culture standard operating procedure in the emergency department]. Orth, HM
Al Agha, S
Kempe, M
Mackenzie, C
Michael, M
Bernhard, M
Jensen, B-O
2021 Medizinische Klinik, Intensivmedizin und Notfallmedizin
8 (116), pp. 687-693
10. An Experimental Study on the Rheological Behavior of Carbon Black-Boron Nitride Hybrid Nanofluids and Development of a New Correlation. Michael, M
Zagabathuni, A
Kumar Pabi, S
Ghosh, S
2021 Journal of nanoscience and nanotechnology
6 (21), pp. 3283-3290
11. Complete pathological response in rectal cancer utilising novel treatment strategies for neo-adjuvant therapy: A systematic review. Wilson, K
Flood, M
Narasimhan, V
Pham, T
Warrier, S
Ramsay, R
Michael, M
Heriot, A
2021 European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology
8 (47), pp. 1862-1874
12. Dural Venous Sinus Stenosis: Why Distinguishing Intrinsic-versus-Extrinsic Stenosis Matters. Sundararajan, SH
Ramos, AD
Kishore, V
Michael, M
Doustaly, R
DeRusso, F
Patsalides, A
2021 AJNR. American journal of neuroradiology
2 (42), pp. 288-296
13. [Nontraumatic resuscitation room management of critically ill patients]. Michael, M
Kumle, B
Pin, M
Kümpers, P
Gröning, I
Bernhard, M
2021 Medizinische Klinik, Intensivmedizin und Notfallmedizin
5 (116), pp. 405-414
14. Impact of gas micro-nano-bubbles on the efficacy of commonly used antimicrobials in the food industry. Singh, A
Sekhon, AS
Unger, P
Babb, M
Yang, Y
Michael, M
2021 Journal of applied microbiology
4 (130), pp. 1092-1105
15. Association between imaging response and survival following neoadjuvant chemotherapy in patients with resectable colorectal liver metastases: A cohort study. Behrenbruch, C
Prabhakaran, S
Udayasiri D, D
Michael, M
Hollande, F
Hayes, I
Heriot, AG
Knowles, B
Thomson, BN
2021 Journal of surgical oncology
5 (123), pp. 1263-1273
16. TEMPORARY REMOVAL: OC-15: Targeted thromboprophylaxis in ambulatory patients receiving anticancer therapies for lung or gastrointestinal cancers (TARGET-TP); a randomized trial. Alexander, M
Harris, SJ
Underhill, C
Torres, J
Sharma, S
Lee, N
Wong, H
Eek, R
Michael, M
Tie, J
Rogers, J
Heriot, A
Ball, D
MacManus, M
Wolfe, R
Solomon, B
Burbury, K
2022 Thrombosis research
(213), pp. S9
17. TEMPORARY REMOVAL: PO-44: Risk assessment model potency to detect patients most likely to benefit from thromboprophylaxis: an application of the TARGET- TP score. Alexander, M
Harris, SJ
Underhill, C
Torres, J
Sharma, S
Lee, N
Wong, H
Eek, R
Michael, M
Tie, J
Rogers, J
Heriot, A
Ball, D
MacManus, M
Wolfe, R
Solomon, B
Burbury, K
2022 Thrombosis research
(213), pp. S31-S32

Title Authors Year Journal title Cited count
< 2017 2018 2019 2020 2021 2022 Total
1. Nitrogen loss from Titan VI Shematovich
RE Johnson
M Michael
JG Luhmann
2003 JOURNAL OF GEOPHYSICAL RESEARCH-PLANETS
E8 (108.0), pp.
45 0 0 0 0 0 45
2. Ejection of nitrogen from Titan's atmosphere by magnetospheric ions and pick-up ions M Michael
RE Johnson
F Leblanc
M Liu
JG Luhmann
VI Shematovich
2005 ICARUS
1.0 (175.0), pp. 263.0-267.0
44 0 0 0 0 0 44
3. Energy deposition of pickup ions and heating of Titan's atmosphere M Michael
RE Johnson
2005 PLANETARY AND SPACE SCIENCE
14-15 (53.0), pp. 1510.0-1514.0
37 0 0 0 0 0 37
4. A phase I/II trial of celecoxib with chemotherapy and radiotherapy in the treatment of patients with locally advanced oesophageal cancer S. J. Dawson
M. Michael
J. Biagi
K. F. Foo
M. Jefford
S. Y. Ngan
T. Leong
A. Hui
A. D. Milner
R. J. S. Thomas
J. R. Zalcberg
2007 INVESTIGATIONAL NEW DRUGS
2.0 (25.0), pp. 123.0-129.0
21 0 0 0 0 0 21
5. Cassini Ion and Neutral Mass Spectrometer data in Titan's upper atmosphere and exosphere: Observation of a suprathermal corona V. De la Haye
J. H. Waite
R. E. Johnson
R. V. Yelle
T. E. Cravens
J. G. Luhmann
W. T. Kasprzak
D. A. Gell
B. Magee
F. Leblanc
M. Michael
S. Jurac
I. P. Robertson
2007 JOURNAL OF GEOPHYSICAL RESEARCH-SPACE PHYSICS
A7 (112.0), pp.
63 0 0 0 0 0 63
6. Gemcitabine with a specific conformal 3D 5FU radiochemotherapy technique is safe and effective in the definitive management of locally eadvanced pancreatic cancer D. Goldstein
G. Van Hazel
E. Walpole
C. Underhill
D. Kotasek
M. Michael
J. Shapiro
T. Davies
W. Reece
J. Harvey
N. Spry
2007 BRITISH JOURNAL OF CANCER
4.0 (97.0), pp. 464.0-471.0
34 0 0 0 0 0 34
7. A phase II trial of lomeguatrib and temozolomide in metastatic colorectal cancer O. A. Khan
M. Ranson
M. Michael
I. Olver
N. C. Levitt
P. Mortimer
A. J. Watson
G. P. Margison
R. Midgley
M. R. Middleton
2008 BRITISH JOURNAL OF CANCER
10.0 (98.0), pp. 1614.0-1618.0
25 0 0 0 0 0 25
8. Dust charging and electrical conductivity in the day and nighttime atmosphere of Mars M. Michael
S. N. Tripathi
S. K. Mishra
2008 JOURNAL OF GEOPHYSICAL RESEARCH-PLANETS
E7 (113.0), pp.
17 0 0 0 0 0 17
9. Cetuximab plus chemotherapy in patients with advanced non-small-cell lung cancer (FLEX): an open-label randomised phase III trial Robert Pirker
Jose R. Pereira
Aleksandra Szczesna
Joachim von Pawel
Maciej Krzakowski
Rodryg Ramlau
Ihor Vynnychenko
Keunchil Park
Chih-Teng Yu
Valentyn Ganul
Jae-Kyung Roh
Emilio Bajetta
Kenneth O'Byrne
Filippo de Marinis
Wilfried Eberhardt
Thomas Goddemeier
Michael Emig
Ulrich Gatzemeier
N. Thatcher
J. P. Armand
P. Camus
N. Victor
M. Emig
M. Mueser
K. Pilz
T. Goddemeier
I. Montaner
Martin Lachs
Loan Hoang-Sayag
A. Alvarez
F. Coppola
G. Recondo
E. Richardet
F. Kirsten
C. Karapetis
P. Parente
M. Michael
S. White
A. Boyce
C. Lewis
M. Slancar
N. Pavlakis
E. Abdi
C. Underhill
K. Pittman
O. Burghuber
R. Pirker
R. Ruckser
E. Ulsperger
R. Kolb
Y. Humblet
J-L. Canon
F. Bustin
C. Barrios
C. Gorini
C. Moreira Ferreira
J. Pereira
N. Ivanova
A. Tomova
V. Tzekova
P. Chilingirov
M. Racheva
M. Gill
F. Javier Orlandi
J. Reyes
P. Salman
M. Tomiskova
J. Roubec
M. Pesek
J. Musil
P. Zatloukal
G. Robinet
A. Riviere
D. Moro-Sibilot
F. Barlesi
C. Chouaid
J-M. Tourani
H. Lena
L. Thiberville
E. Quoix
R. Schott
E. Lemarie
G. Schlimok
R. Loddenkemper
W. Eberhardt
H. Wilke
U. Martens
C. Waller
J. von Pawel
F. Griesinger
U. Gatzemeier
W. Schuette
C. Eschbach
H. Bischoff
A. Chemaissani
J. Wolf
J. Fischer
S. Bohnet
H. Klein
C. Kortsik
C. Peschel
T. H. Ittel
W. Fett
D. Chua
P. Magyar
G. Ostoros
A. Somfay
I. Vinkler
Z. Papai
B. Szima
Z. Mark
S. Tehenes
K. O'Byrne
A. Brandes
A. Martoni
G. Marini
F. Artioli
E. Bajetta
S. Siena
F. de Marinis
A. Santoro
S. Barni
G. Berchem
O. Arrieta
J. Figueroa
L. Martinez
E. Llerena
J. A. Burgers
G. Giaccone
F. M. N. H. Schramel
S. H. Goey
J. A. Stigt
G. Jagiello
A. Jagiello-Gruszfeld
A. Szczesna
R. Ramlau
M. Krzakowski
J. Tomeczko
E. Teixeira
B. Parente
G. Kononova
M. Biakhov
V. Borisov
V. Gorbunova
A. Konev
L. Manzuk
Y. Lukyanov
G. Manikhas
S. Orlov
D-S. Heo
S-W. Kim
K. Park
J-K. Roh
J-H. Choi
R. Soo
J. Mazal
P. Kasan
P. Berzinec
M. Prochazka
A. Carrato
R. Bastus Pivlots
P. Lianes
J. Villar
L. Paz-Ares
M. Cobo
J. M. Trigo
A. Gurpide Ayarra
M. Constenla
A. Paredes Lario
M. Lopez Brea
A. Insa
G. Lopez Vivanco
O. Brodin
G. Wagenius
A. Ochsenbein
D. Rauch
A. Knuth
G-C. Chang
R. P. Perng
C-H. Yang
C-T. Yu
A. Demirkazik
F. Demirelli
M. Nicolson
S. Falk
A. Price
C. Mulatero
S. M. Lee
M. O'Brien
J. Gardiner
V. Laurence
D. Ferry
V. Paramonov
I. Bondarenko
M. Pylypenko
V. Ganul
P. Oliynichenko
S. Simonov
Y. Shparyk
V. Bashtan
I. Vynnychenko
I. Galaychuk
Y. Hotko
2009 LANCET
9674.0 (373.0), pp. 1525.0-1531.0
801 0 0 0 0 0 801
10. Molecular markers of response and toxicity to FOLFOX chemotherapy in metastatic colorectal cancer W. Chua
D. Goldstein
C. K. Lee
H. Dhillon
M. Michael
P. Mitchell
S. J. Clarke
B. Iacopetta
2009 BRITISH JOURNAL OF CANCER
6.0 (101.0), pp. 998.0-1004.0
50 0 0 0 0 0 50
11. Safety and efficacy of first-line bevacizumab with FOLFOX, XELOX, FOLFIRI and fluoropyrimidines in metastatic colorectal cancer: the BEAT study E. Van Cutsem
F. Rivera
S. Berry
A. Kretzschmar
M. Michael
M. DiBartolomeo
M. -A. Mazier
J. -L. Canon
V. Georgoulias
M. Peeters
J. Bridgewater
D. Cunningham
2009 ANNALS OF ONCOLOGY
11.0 (20.0), pp. 1842.0-1847.0
297 0 0 0 0 0 297
12. BENDAMUSTINE IN PATIENTS WITH RELAPSED OR REFRACTORY MULTIPLE MYELOMA M. Michael
I. Bruns
E. Boelke
F. Zohren
A. Czibere
N. N. Safaian
F. Ncumann
R. Haas
G. Kobbe
R. Fenk
2010 EUROPEAN JOURNAL OF MEDICAL RESEARCH
1.0 (15.0), pp. 13.0-19.0
23 0 0 0 0 0 23
13. BENDAMUSTINE IN PATIENTS WITH RELAPSED OR REFRACTORY MULTIPLE MYELOMA M. Michael
I. Bruns
E. Boelke
F. Zohren
A. Czibere
N. N. Safaian
F. Ncumann
R. Haas
G. Kobbe
R. Fenk
2010 EUROPEAN JOURNAL OF MEDICAL RESEARCH
1.0 (15.0), pp. 13.0-19.0
23 0 0 0 0 0 23
14. Open-label, phase I dose-escalation study of sodium selenate, a novel activator of PP2A, in patients with castration-resistant prostate cancer N. M. Corcoran
C. M. Hovens
M. Michael
M. A. Rosenthal
A. J. Costello
2010 BRITISH JOURNAL OF CANCER
4.0 (103.0), pp. 462.0-468.0
20 0 0 0 0 0 20
15. Plant breeding and climate changes S. Ceccarelli
S. Grando
M. Maatougui
M. Michael
M. Slash
R. Haghparast
M. Rahmanian
A. Taheri
A. Al-Yassin
A. Benbelkacem
M. Labdi
H. Mimoun
M. Nachit
2010 JOURNAL OF AGRICULTURAL SCIENCE
(148.0), pp. 627.0-637.0
55 0 0 0 0 0 55
16. FDG-PET metabolic response predicts outcomes in anal cancer managed with chemoradiotherapy F. L. Day
E. Link
S. Ngan
T. Leong
K. Moodie
C. Lynch
M. Michael
E. de Winton
A. Hogg
R. J. Hicks
A. Heriot
2011 BRITISH JOURNAL OF CANCER
4.0 (105.0), pp. 498.0-504.0
22 0 0 0 0 0 22
17. FDG-PET metabolic response predicts outcomes in anal cancer managed with chemoradiotherapy F. L. Day
E. Link
S. Ngan
T. Leong
K. Moodie
C. Lynch
M. Michael
E. de Winton
A. Hogg
R. J. Hicks
A. Heriot
2011 BRITISH JOURNAL OF CANCER
4.0 (105.0), pp. 498.0-504.0
22 0 0 0 0 0 22
18. Metabolic Response of Rectal Cancer Assessed by 18-FDG PET Following Chemoradiotherapy is Prognostic for Patient Outcome J. M. C. Yeung
V. Kalff
R. J. Hicks
E. Drummond
E. Link
Y. Taouk
M. Michael
S. Ngan
A. C. Lynch
A. G. Heriot
2011 DISEASES OF THE COLON & RECTUM
5.0 (54.0), pp. 518.0-525.0
21 0 0 0 0 0 21
19. ACTING PSYCHIATRY C. Hickie
M. Michael
2014 AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY
(48.0), pp. 69.0-70.0
0 0 0 0 0 0 0
20. Additive glycaemic control of the combination of a single dose of empagliflozin with injectable antidiabetes drugs in ZDF rats E. K. Naderali
L. Thomas
R. Grempler
M. Michael
E. Mayoux
A. Tahbaz
2014 DIABETIC MEDICINE
(31.0), pp. 65.0-66.0
0 0 0 0 0 0 0
21. A Phase II Trial of Integrated Preoperative Radiotherapy and Chemotherapy with Oxaliplatin 5-Fluorouracil and Folinic Acid in Patients with Locally Advanced Rectal Cancer: Trans-Tasman Radiation Oncology Group TROG 09.01 S. Ngan
M. Bressel
B. McClure
S. Chander
J. McKendrick
M. Steel
J. Mackay
P. Cooray
M. Kumar
A. Strickland
A. Heriot
T. Leong
M. Michael
2014 INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
(90.0), pp. S21-S22
1 0 0 0 0 0 1
22. Assessment of predictors of response and long-term survival of patients with neuroendocrine tumour treated with peptide receptor chemoradionuclide therapy (PRCRT) G. Kong
M. Thompson
M. Collins
A. Herschtal
M. S. Hofman
V. Johnston
P. Eu
M. Michael
Rodney J. Hicks
2014 EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
10.0 (41.0), pp. 1831.0-1844.0
14 0 0 0 0 0 14
23. AUDIT OF UPPER GI UNIT REFERRALS TO THE FAMILIAL CANCER CENTRE T. Schenberg
M. Michael
2014 ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY
(10.0), pp. 65.0-66.0
0 0 0 0 0 0 0
24. CREATIVE PRACTITIONERS S. Kumar
C. Hickie
L. McLean
M. Michael
A. Pal
N. Phillips
2014 AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY
(48.0), pp. 69.0-69.0
0 0 0 0 0 0 0
25. Disruption of cortical tension patterning drives the outgrowth of oncogenic cells S. Wu
G. A. Gomez
M. Michael
S. Verma
H. Cox
J. G. Lefevre
R. G. Parton
N. A. Hamilton
A. S. Yap
2014 EUROPEAN JOURNAL OF CANCER
(50.0), pp. S67-S67
0 0 0 0 0 0 0
26. Phase II trial evaluating the feasibility of interdigitating folfox with chemoradiotherapy in locally advanced and metastatic rectal cancer M. Michael
S. Chander
J. McKendrick
J. R. MacKay
M. Steel
R. Hicks
A. Heriot
T. Leong
P. Cooray
M. Jefford
J. Zalcberg
M. Bressel
B. McClure
S. Y. Ngan
2014 BRITISH JOURNAL OF CANCER
10.0 (111.0), pp. 1924.0-1931.0
2 0 0 0 0 0 2
27. Practicing Excellence in Transfusion: The Results of a Performance Improvement Project to Reduce Red Blood Cell Utilization at Virginia Commonwealth University, Richmond, Virginia M. Michael
B. Dahman
S. Roseff
M. Ailes
N. Benoit
2014 TRANSFUSION
8.0 (54.0), pp. 11A-12A
0 0 0 0 0 0 0
28. Preserved levels of uninvolved immunoglobulins are independently associated with favorable outcome in patients with symptomatic multiple myeloma E. Kastritis
F. Zagouri
A. Symeonidis
M. Roussou
A. Sioni
A. Pouli
S. Delimpasi
E. Katodritou
E. Michalis
M. Michael
E. Hatzimichael
A. Vassou
P. Repousis
A. Christophoridou
Z. Kartasis
E. Stefanoudaki
C. Megalakaki
S. Giannouli
M-C Kyrtsonis
K. Konstantopoulos
M. Spyroupoulou-Vlachou
E. Terpos
M. A. Dimopoulos
2014 LEUKEMIA
10.0 (28.0), pp. 2075.0-2079.0
7 0 0 0 0 0 7
29. Prison health as public health in Afghanistan? A policy analysis of the on-going reform process M. Michael 2014 PUBLIC HEALTH
5.0 (128.0), pp. 478.0-481.0
0 0 0 0 0 0 0
30. Significant improvement in the survival of patients with multiple myeloma presenting with severe renal impairment after the introduction of novel agents M. A. Dimopoulos
S. Delimpasi
E. Katodritou
A. Vassou
M. C. Kyrtsonis
P. Repousis
Z. Kartasis
A. Parcharidou
M. Michael
E. Michalis
D. Gika
A. Symeonidis
A. Pouli
K. Konstantopoulos
E. Terpos
E. Kastritis
2014 ANNALS OF ONCOLOGY
1.0 (25.0), pp. 195.0-200.0
29 0 0 0 0 0 29
31. Single dose of empagliflozin in combination with other oral antidiabetes drugs further improves glucose tolerance in ZDF rats A. Tahbaz
G. Luippold
L. Thomas
M. Michael
E. Mayoux
E. K. Naderali
2014 DIABETIC MEDICINE
(31.0), pp. 65.0-65.0
0 0 0 0 0 0 0
32. SOCIAL CONSTRAINT AMONGST PEOPLE WITH ADVANCED CANCER: A CORRELATE WITH STIGMATISATION AND ANXIETY Nicole Hennessy Anderson
P. Schofield
S. Aranda
S. Chambers
M. Krishnasamy
D. Ball
M. Michael
P. Kenny
R. Lipson-Smith
I. Stubbins
A. Ugalde
2014 ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY
(10.0), pp. 128.0-128.0
0 0 0 0 0 0 0
33. The effects of empagliflozin, a novel sodium glucose cotransporter-2 inhibitor, on glucose homeostasis and pancreatic beta cell mass in db/db mice E. Mayoux
T. Klein
R. Grempler
M. Michael
A. Tahbaz
E. K. Naderali
2014 DIABETIC MEDICINE
(31.0), pp. 66.0-66.0
0 0 0 0 0 0 0
34. The novel SGLT-2 inhibitor, empagliflozin, prevents pioglitazone-induced weight gain and further improves glycaemic control in dietary-induced obese rats E. K. Naderali
R. Grempler
L. Thomas
A. Sauer
M. Michael
P. Eickelmann
T. Klein
E. Mayoux
A. Tahbaz
2014 DIABETIC MEDICINE
(31.0), pp. 66.0-66.0
0 0 0 0 0 0 0
35. The Safety and Tolerability of Veliparib (V) plus Capecitabine (C) and Radiation (RT) in Subjects with Locally Advanced Rectal Cancer (LARC): Results of a Phase 1b Study B. Czito
M. Mulcahy
W. Schelman
H. Vaghefi
J. Gayle
A. Deluca
H. Xiong
W. Munasinghe
D. Matthew
K. Holen
M. Michael
2014 INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
(90.0), pp. S22-S22
0 0 0 0 0 0 0
36. Validation of radio-frequency dielectric heating system for destruction of Cronobacter sakazakii and Salmonella species in nonfat dry milk M. Michael
R. K. Phebus
H. Thippareddi
J. Subbiah
S. L. Birla
K. A. Schmidt
2014 JOURNAL OF DAIRY SCIENCE
12.0 (97.0), pp. 7316.0-7324.0
3 0 0 0 0 0 3
37. Safety and Tolerability of Veliparib Combined With Capecitabine Plus Radiation Therapy in Patients With Locally Advanced Rectal Cancer: Final Results of a Phase 1b Study B. Czito
M. Mulcahy
D. Deming
H. Vaghefi
G. Jameson
A. DeLuca
H. Xiong
W. Munasinghe
M. Dudley
P. Komarnitsky
K. Holen
M. Michael
2015 INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
3.0 (93.0), pp. S206-S206
1 0 0 0 0 0 1
38. The Clinical Oncology Society of Australia (COSA) SIGNETURe Neuroendocrine Tumor (NET) Registry of Australia: First Report of Patient Characteristics and Patterns of Care T. Price
N. Pavlakis
C. Karapetis
M. Michael
N. Singhal
D. Goldstein
G. Van Hazel
J. Zalcberg
R. Hicks
S. Yeend
Y. J. Chua
2015 NEUROENDOCRINOLOGY
1-2 (102.0), pp. 98.0-98.0
0 0 0 0 0 0 0
39. A 12-week regimen with interdigitating FOLFOX/bevacizumab and pelvic chemoradiation for synchronous primary and metastatic rectal cancer. The CHROME B trial S. Ngan
M. Bressel
J. Chu
J. McKendrick
S. Chander
P. Cooray
M. Jefford
R. Wong
M. Steel
T. Leong
A. Heriot
M. Michael
2016 ANNALS OF ONCOLOGY
(27.0), pp.
0 0 0 0 0 0 0
40. A photochemicalmodel of the dust-loaded ionosphere of Mars S. Cardnell
O. Witasse
G. J. Molina-Cuberos
M. Michael
S. N. Tripathi
G. Deprez
F. Montmessin
K. O'Brien
2016 JOURNAL OF GEOPHYSICAL RESEARCH-PLANETS
11.0 (121.0), pp. 2335.0-2348.0
1 0 0 0 0 0 1
41. Favourable responses in Patients with Bulky Neuroendocrine Tumours (NET) A Personalised Approach Using 90Y-DOTA-Octreotate Sequenced with 177Lu-DOTA-Octreotate Induction Peptide Receptor Chemoradionuclide Therapy (PRCRT) G. Kong
J. Callahan
M. Hofman
D. Pattison
T. Akhurst
M. Michael
P. Eu
R. Hicks
2016 NEUROENDOCRINOLOGY
(103.0), pp. 93.0-93.0
0 0 0 0 0 0 0
42. Genomic Variants in the SLCO1B3 Gene May Serve as Pharmacogenomic Biomarkers upon Cancer Drug Administration A. Stratopoulos
M. Michael
C. -V. Zafeiri
E. Daki
T. Katsila
G. P. Patrinos
2016 PUBLIC HEALTH GENOMICS
(19.0), pp. 8.0-9.0
0 0 0 0 0 0 0
43. HIGH EFFICACY FROM A PERSONALISED APPROACH USING Y-90-DOTA-OCTREOTATE SEQUENCED WITH (LU)-L-177-DOTA-OCTREOTATE INDUCTION PEPTIDE RECEPTOR CHEMORADIONUCLIDE THERAPY (PRCRT) FOR BULKY NEUROENDOCRINE TUMOURS G. Kong
J. Callahan
M. Hofman
D. Pattison
T. Akhurst
M. Michael
P. Eu
R. Hicks
2016 INTERNAL MEDICINE JOURNAL
(46.0), pp. 25.0-25.0
0 0 0 0 0 0 0
44. Ledipasvir/Sofosbuvir (LDV/SOF) for 12 or 24 Weeks Is Safe and Effective in Kidney Transplant Recipients with Chronic Genotype 1 or 4 HCV Infection S. Pol
A. Aghemo
L. Lin
R. Hyland
C. Yun
J. Spellman
M. Natha
D. Brainard
J. McHutchison
M. Bourliere
M. Peck-Radosavljevic
M. Michael
M. Colombo
2016 AMERICAN JOURNAL OF TRANSPLANTATION
(16.0), pp. 262.0-262.0
1 0 0 0 0 0 1
45. PRELIMINARY RESULTS OF (68)GA EXENDIN-4 PET/CT IMAGING OF NEUROENDOCRINE TUMOURS (NETS) D. Pattison
G. Kong
B. Messazos
P. Hamblin
S. Fourlanos
M. Lee
M. Michael
E. Hong
P. Eu
R. Hicks
2016 INTERNAL MEDICINE JOURNAL
(46.0), pp. 23.0-23.0
0 0 0 0 0 0 0
46. THE ENDOTHELIAL PHD2/HIF-2 AXIS REGULATES PULMONARY ARTERY PRESSURE IN MICE P. P. Kapitsinou
G. Rajendran
L. Astleford
M. P. Schonfeld
M. Michael
S. Shay
J. L. French
J. West
V. H. Haase
T. Fields
2016 JOURNAL OF INVESTIGATIVE MEDICINE
4.0 (64.0), pp.
0 0 0 0 0 0 0
47. UNIVERSITY OF SOUTH FLORIDA, TAMPA FAMILY HEALTH CENTER, AND SENIOR CONNECTION PARTNERSHIP R. DAoust
K. Hyer
L. Guerra
A. Badana
F. Syed
C. McHenry
M. Michael
C. Wilson
2016 GERONTOLOGIST
(56.0), pp. 449.0-449.0
0 0 0 0 0 0 0
48. Application of Curriculum Mapping Concepts to Integrate Multidisciplinary Competencies in the Care of Older Adults in Graduate Nurse Practitioner Curricula C. Burkey-Wilson
M. Michael
2017 JOURNAL OF THE AMERICAN GERIATRICS SOCIETY
(65.0), pp. S56-S57
0 0 0 0 0 0 0
49. A REVISED STAGING SYSTEM FOR WALDENSTROM'S MACROGLOBULINEMIA E. Kastritis
M. Gavriatopoulou
M. C. Kyrtsonis
E. Hatjiharissi
E. Katodritou
P. Repousis
A. Symeonidis
M. Michael
A. Pouli
N. Giannakoulas
D. Christoulas
A. Megalakaki
P. Tsirigotis
S. Giannouli
P. Panagiotidis
E. Vervessou
E. Spanoudakis
E. Terpos
M. A. Dimopoulos
2017 HAEMATOLOGICA
(102.0), pp. 146.0-147.0
0 0 0 0 0 0 0
50. FOLFOX and intensified split-course chemoradiation as initial treatment for rectal cancer with synchronous metastases T. Bird
M. Michael
M. Bressel
J. Chu
S. Chander
P. Cooray
J. McKendrick
M. Jefford
A. Heriot
M. Steel
T. Leong
S. Ngan
2017 ACTA ONCOLOGICA
5.0 (56.0), pp. 646.0-652.0
0 0 0 0 0 0 0

Title Authors Year Journal title

Title Authors NRIIS type Year NRIIS Scholarship

0.04060101509094238